|
|
Volumn 5, Issue 8, 1996, Pages 1035-1045
|
|
Beyond the tobacco debate: Dissecting out the therapeutic potential of nicotine
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
2 METHYL 3 (2 PYRROLIDINYLMETHOXY)PYRIDINE;
3 (2,4 DIMETHOXYBENZYLIDENE)ANABASEINE;
3 ETHYNYL 5 (1 METHYL 2 PYRROLIDINYL)PYRIDINE;
3 METHYL 5 (1 METHYL 2 PYRROLIDINYL)ISOXAZOLE;
EPIBATIDINE;
ION CHANNEL;
NICOTINE;
NICOTINIC AGENT;
NICOTINIC RECEPTOR;
UNCLASSIFIED DRUG;
ADDICTION;
ALZHEIMER DISEASE;
ANIMAL MODEL;
ATTENTION DEFICIT DISORDER;
CENTRAL NERVOUS SYSTEM;
CHRONIC PAIN;
CIGARETTE SMOKING;
CLINICAL TRIAL;
ENTERITIS;
EPIDEMIOLOGY;
EPILEPSY;
HUMAN;
MENTAL DISEASE;
NONHUMAN;
PARKINSON DISEASE;
PERIPHERAL NERVOUS SYSTEM;
PROSTATE DISEASE;
PUBLIC HEALTH;
REVIEW;
SCHIZOPHRENIA;
SLEEP APNEA SYNDROME;
TOBACCO;
|
|
EID: 0029764502
PISSN: 13543784
EISSN: None
Source Type: Journal
DOI: 10.1517/13543784.5.8.1035 Document Type: Review |
|
Times cited : (29)
|
|
References (0)
|
